The test could help to extend or save lives, by targeting treatment more effectively.

Kolkata, Sep 26 (IANS) Bolstering the knowhow behind targeted cancer treatment, Indian scientists have offered a new rationale for combinat...

Women who carried rare mutations in PALB2 were found to have on average a one in three chance of developing breast cancer by the age of 70.